Release of tumor necrosis factor-α and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin

• Principais autores: Ilse Beckmann (Autor), Shlomo Ben-Efraim (Autor), Monica Vervoort (Autor), Henk C. S. Wallenburg (Autor)
• Formato: Livro
• Publicado em: Hindawi Limited, 2001-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: The preventive effect of low-dose aspirin in cardiovascular disease is generally attributed to its antiplatelet action caused by differential inhibition of platelet cyclooxygenase-1. However, there is evidence that aspirin also affects release of inflammatory cytokines, including tumor n...